Literature DB >> 19716737

Results of extraocular muscle surgery for superior oblique myokymia.

Swati Agarwal1, Burton J Kushner.   

Abstract

PURPOSE: To report results of extraocular muscle surgery for superior oblique myokymia when medical treatment fails.
METHODS: A retrospective review of 14 consecutive patients undergoing superior oblique tenectomy and inferior oblique myectomy between 1976 and 2008.
RESULTS: The mean age of onset of symptoms was 35.4 +/- 12.6 years (range, 16-59.5), with a mean duration of oscillopsia of 5 +/- 4 years (range, 1.5-17) prior to surgery. Medical treatment was unsuccessful in all 14. Preoperatively, 2 had a small hypertropia that was consistent with an ipsilateral fourth (trochlear) nerve palsy; 12 had no manifest tropia. Postoperatively, all had complete elimination of oscillopsia, and 12 of 14 were free of diplopia in the primary position at 6 meters and 1/3 meter. The only 2 with diplopia in the primary position after surgery were the 2 with a manifest hypertropia preoperatively. Of the remaining 12 patients, 5 had a hypertropia of the affected eye limited to downgaze after surgery (mean of 6.2(Delta) +/- 1.6(Delta)). Of the 5, 3 needed contralateral inferior rectus surgery, and 1 required prism for downgaze. The mean follow-up was 4.1 +/- 2.4 years (range, 0.5-10). At the final visit, none had oscillopsia or uncontrolled diplopia, but 3 (21%) needed prisms.
CONCLUSIONS: Superior oblique tenectomy and inferior oblique myectomy effectively eliminate oscillopsia associated with superior oblique myokymia but result in diplopia in downgaze in approximately 36% of patients, which may cause symptoms in patients who require a bifocal for near work.

Entities:  

Mesh:

Year:  2009        PMID: 19716737     DOI: 10.1016/j.jaapos.2009.05.012

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  5 in total

1.  Functional imaging of human extraocular muscles in head tilt dependent hypertropia.

Authors:  Joseph L Demer; Jennifer Kung; Robert A Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-09       Impact factor: 4.799

Review 2.  Topical timolol in the treatment of monocular oscillopsia secondary to superior oblique myokymia: a review.

Authors:  Christopher J Borgman
Journal:  J Optom       Date:  2013-08-02

Review 3.  Therapy of Vestibular Paroxysmia, Superior Oblique Myokymia, and Ocular Neuromyotonia.

Authors:  Michael Strupp; Marianne Dieterich; Thomas Brandt; Katharina Feil
Journal:  Curr Treat Options Neurol       Date:  2016-07       Impact factor: 3.598

4.  Recurrent Superior Oblique Myokymia Treated by Distal Tendon Extirpation.

Authors:  Megan X Law; Creig S Hoyt; Jonathan C Horton
Journal:  J Neuroophthalmol       Date:  2019-09       Impact factor: 3.042

5.  Superior Oblique Myokymia: Some Novel Observations.

Authors:  Sanitha Sathyan; Rosemary C Antony
Journal:  Middle East Afr J Ophthalmol       Date:  2017 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.